Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Credo Technology Group Holding Ltd (CRDO) vs Medline Inc. Class A Common Stock (MDLN) Price & Performance

Credo Technology Group Holding LtdTrade
Medline Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Credo Technology Group Holding Ltd vs Medline Inc. Class A Common Stock — how do they compare? Credo Technology Group Holding Ltd trades at $216.95 (market cap $41.35B), while Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B). The key difference: Credo Technology Group Holding Ltd is the larger of the two by market cap, and Credo Technology Group Holding Ltd is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Credo Technology Group Holding Ltd for 22 Days and Medline Inc. Class A Common Stock for 0 Days on average.

CRDOMDLN
Market Cap
$41.35B$31.10B
Volume
7,290,5084,471,639
Sector
TechnologyHealth
52-Week High
$302.52$49.99
52-Week Low
$87.81$31.64
Typical Hold Time
22 Days0 Days
Enterprise Value
$40.61B$41.07B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Credo Technology Group Holding Ltd

CRDO trades at $220.01, down 0.37% on the day, with strong technical momentum indicated by bullish moving averages and key support at $213. The company demonstrates exceptional fundamental strength with 114.7% YoY revenue growth in Q2 2026 and a 33.83% net income margin. Recent news highlights Credo's positioning as a key beneficiary of AI infrastructure spending, with triple-digit revenue growth driven by high-speed connectivity solutions for data centers.

Outlook remains positive with 87.5% analyst buy ratings and a $267.33 consensus price target representing 21.5% upside. Key risks include premium valuation multiples (P/E 77.47) and customer concentration, while growth catalysts center on AI-driven demand and expanding optical product offerings. The stock's recent 20.3% monthly decline may present a buying opportunity given strong fundamentals.

Medline Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRDO
46% Buy54% Sell
Avg holding period · 22 Days
MDLN
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Credo Technology Group Holding Ltd

Credo Technology provides high-speed connectivity solutions for AI-driven applications and hyperscale data centers. Its products enable faster, more energy-efficient data transmission for cloud and telecom infrastructure.

Read more on CRDO →

About Medline Inc. Class A Common Stock

Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.

Read more on MDLN →